Institute of Medicine of the National Academies (IOM)

Meeting 1: Public Health Effectiveness of the FDA 510(k) Clearance Process, March 1, 2010

Meeting 2: Public Health Effectiveness of the FDA 510(k) Clearance Process, June 14-15, 2010

Agenda (pdf)
Biographical Information for Invited Speakers and Panelists (pdf)
Webcast: Public Health Effectiveness of the FDA 510(k) Clearance Process, Workshop 1
Philip Phillips: Premarket Notification-A Key Element of US Medical Device Regulation
(June 14, 2010) (pdf)
Timothy Ulatowski: FDA's Compliance Infrastructure (June 14, 2010) (pdf)
Josh Makower: The Structure of the MedTech Innovation Ecosystem (June 14, 2010) (pdf)
David Feigal: Impact of the Regulatory Framework on Medical Device Development and Innovation (June 14, 2010) (pdf)
David Jefferys: Comparative Overview of Other Medical Device Regulatory Systems (June 15, 2010) (pdf)
Janet Trunzo: Global Harmonization Task Force (June 15, 2010) (pdf)
Doug Mowen: PwC Medical Technology Innovation Scorecard (June 15, 2010) (pdf)

Meeting 3: Public Health Effectiveness of the FDA 510(k) Clearance Process, July 28, 2010

Agenda (pdf)
Biographical Information for Speakers and Panelists (pdf)
Webcast: Public Health Effectiveness of the FDA 510(k) Clearance Process Workshop
Kevin Fu: Trustworthy Medical Device Software (pdf)
Rita Redberg: Strength of Study Evidence Examined by the FDA in Premarket Approval of Cardiovascular Devices (pdf)
Robert Fischell: Issues with the Present FDA on the Matter of FDA 510(k) Clearance (pdf)
Susan Gardner: Monitoring Device Safety: CDHR's Current System and Vision for the Future (pdf)
William Maisel: Premarket Notification: Analysis of FDA Recall Data (pdf)
Ralph Hall: Using Recall Data to Assess the 510(k) Process (pdf)
Frederick Masoudi: National Cardiovascular Data Registries (pdf)
Paul Varosy: The Veterans Health Administration CART Program (pdf)
Eric Peterson: Use of Registry Data for Postmarket Device Surveillance (pdf)
Frederic Resnic: The DELTA Project (pdf)

Reports